- TXMD Dashboard
- Financials
- Filings
-
Holdings
- Transcripts
- ETFs
- Insider
- Institutional
- Shorts
-
PREM14A Filing
TherapeuticsMD (TXMD) PREM14APreliminary proxy related to merger
Filed: 30 Jan 07, 12:00am
CAUSEY DEMGEN & MOORE INC.
Certified Public Accountants and Consultants
Suite 4650 | |
1801 California Street | |
Denver, Colorado 80202-2681 | |
Telephone: (303) 296-2229 | |
Facsimile: (303) 296-3731 | |
www.cdmcpa.com |
Exhibit 23.1
CONSENT OF REGISTERED PUBLIC ACCOUNTING FIRM
In connection with the foregoing 2007 Annual Proxy Statement on Form 14-A to be fled with the
Washington, D.C. Offce of the U.S. Securities and Exchange Commission, we hereby consent to the inclusion of our report dated March 17, 2006 related to the audit of the financial statements of Croff Enterprises, Inc. as of December 31, 2004 and 2005, and for each of the three years in the period ended December 31, 2005.
| Denver, Colorado | /s/ CAUSEY DEMGEN & MOORE INC. |
We use cookies on this site to provide a more responsive and personalized service. Continuing to browse, clicking I Agree, or closing this banner indicates agreement. See our Cookie Policy for more information.